siRNA therapy decreases triglycerides in clients with rare health condition

.ANALYSIS FEATURE.19 September 2024. Plozasiran minimized triglyceride levels through 80% and lowered the threat of pancreatitis in individuals with persistent chylomicronemia, with or even without a genetic medical diagnosis.